Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Case report of rhabdomyosarcomatous transformation of a primary gastrointestinal stromal tumor (GIST).

Li L, Khalili M, Johannes G, Baratam P, Morano WF, Styler M, Bowne WB, Hou JS.

BMC Cancer. 2019 Sep 13;19(1):913. doi: 10.1186/s12885-019-6085-3.

2.

Malate-aspartate shuttle promotes l-lactate oxidation in mitochondria.

Altinok O, Poggio JL, Stein DE, Bowne WB, Shieh AC, Snyder NW, Orynbayeva Z.

J Cell Physiol. 2019 Sep 6. doi: 10.1002/jcp.29160. [Epub ahead of print]

PMID:
31490559
3.

Non-Thermal Plasma-Induced Immunogenic Cell Death in Cancer: A Topical Review.

Khalili M, Daniels L, Lin A, Krebs FC, Snook AE, Bekeschus S, Bowne WB, Miller V.

J Phys D Appl Phys. 2019 Oct 22;52(42). pii: 423001. doi: 10.1088/1361-6463/ab31c1. Epub 2019 Aug 6.

PMID:
31485083
4.

Slippery Nanoparticles as a Diffusion Platform for Mucin Producing Gastrointestinal Tumors.

Khalili M, Zhou H, Thadi A, Daniels L, Fan Z, Morano WF, Ang J, Goldstein E, Polyak B, Mapow BC, Cheng H, Bowne WB.

Ann Surg Oncol. 2019 Jun 11. doi: 10.1245/s10434-019-07493-7. [Epub ahead of print]

PMID:
31187366
5.

Pancreaticoduodenectomy outcomes for locally advanced right colon cancers: A systematic review.

Khalili M, Daniels L, Gleeson EM, Grandhi N, Thandoni A, Burg F, Holleran L, Morano WF, Bowne WB.

Surgery. 2019 Aug;166(2):223-229. doi: 10.1016/j.surg.2019.04.020. Epub 2019 Jun 7.

PMID:
31182232
6.

Erratum: Thadi A.; et al. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018, 6, 54.

Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB.

Vaccines (Basel). 2019 Jan 31;7(1). pii: E15. doi: 10.3390/vaccines7010015.

7.

Patient-specific predictors of failure to rescue after pancreaticoduodenectomy.

Gleeson EM, Clarke JR, Morano WF, Shaikh MF, Bowne WB, Pitt HA.

HPB (Oxford). 2019 Mar;21(3):283-290. doi: 10.1016/j.hpb.2018.07.022. Epub 2018 Aug 22.

PMID:
30143319
8.

Dense and Dynamic Polyethylene Glycol Shells Cloak Nanoparticles from Uptake by Liver Endothelial Cells for Long Blood Circulation.

Zhou H, Fan Z, Li PY, Deng J, Arhontoulis DC, Li CY, Bowne WB, Cheng H.

ACS Nano. 2018 Oct 23;12(10):10130-10141. doi: 10.1021/acsnano.8b04947. Epub 2018 Aug 23.

PMID:
30117736
9.

Reconstruction options following pancreaticoduodenectomy after Roux-en-Y gastric bypass: a systematic review.

Morano WF, Shaikh MF, Gleeson EM, Galvez A, Khalili M, Lieb J 2nd, Renza-Stingone EP, Bowne WB.

World J Surg Oncol. 2018 Aug 13;16(1):168. doi: 10.1186/s12957-018-1467-6. Review.

10.

Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.

Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB.

Vaccines (Basel). 2018 Aug 10;6(3). pii: E54. doi: 10.3390/vaccines6030054. Review. Erratum in: Vaccines (Basel). 2019 Jan 31;7(1):.

11.

Multidisciplinary strategies in bloodless medicine and surgery for patients undergoing pancreatectomy.

Khalili M, Morano WF, Marconcini L, Shaikh MF, Gleeson EM, Styler M, Zebrower M, Bowne WB.

J Surg Res. 2018 Sep;229:208-215. doi: 10.1016/j.jss.2018.04.009. Epub 2018 May 1.

PMID:
29936992
12.

Clinicopathological Features and Management of Appendiceal Mucoceles: A Systematic Review.

Morano WF, Gleeson EM, Sullivan SH, Padmanaban V, Mapow BL, Shewokis PA, Esquivel J, Bowne WB.

Am Surg. 2018 Feb 1;84(2):273-281. Review.

PMID:
29580358
13.

Recurrent Gastrointestinal Stromal Tumors in the Imatinib Mesylate Era: Treatment Strategies for an Incurable Disease.

Platoff RM, Morano WF, Marconcini L, DeLeo N, Mapow BL, Styler M, Bowne WB.

Case Rep Oncol Med. 2017;2017:8349090. doi: 10.1155/2017/8349090. Epub 2017 Nov 30.

14.

Intussusception of the Small Bowel Secondary to Benign Ectopic Prostate Tissue.

Franchini L, Hager S, Edwards DC, Jofre S, Bowne W, Belkoff L.

Urology. 2018 Apr;114:14-17. doi: 10.1016/j.urology.2017.10.026. Epub 2017 Nov 6. No abstract available.

PMID:
29122623
15.

Clinical studies in CRS and HIPEC: Trials, tribulations, and future directions-A systematic review.

Morano WF, Khalili M, Chi DS, Bowne WB, Esquivel J.

J Surg Oncol. 2018 Feb;117(2):245-259. doi: 10.1002/jso.24813. Epub 2017 Nov 9. Review.

16.

Complete Response after Treatment with Neoadjuvant Chemoradiation with Prolonged Chemotherapy for Locally Advanced, Unresectable Adenocarcinoma of the Pancreas.

Pompa TA, Morano WF, Jeurkar C, Li H, Soundararajan S, Poli J, Bowne WB, Styler M.

Case Rep Oncol Med. 2017;2017:7834702. doi: 10.1155/2017/7834702. Epub 2017 Mar 8.

17.

Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.

Gleeson EM, Feldman R, Mapow BL, Mackovick LT, Ward KM, Morano WF, Rubin RR, Bowne WB.

Am J Clin Oncol. 2018 Aug;41(8):777-783. doi: 10.1097/COC.0000000000000376.

PMID:
28263231
18.

Emerging Role of MDM2 as Target for Anti-Cancer Therapy: A Review.

Shaikh MF, Morano WF, Lee J, Gleeson E, Babcock BD, Michl J, Sarafraz-Yazdi E, Pincus MR, Bowne WB.

Ann Clin Lab Sci. 2016 Dec;46(6):627-634. Review.

PMID:
27993876
19.

Incidentally discovered low-grade appendiceal mucinous neoplasm: a precursor to pseudomyxoma peritonei.

Padmanaban V, Morano WF, Gleeson E, Aggarwal A, Mapow BL, Stein DE, Bowne WB.

Clin Case Rep. 2016 Oct 13;4(12):1112-1116. eCollection 2016 Dec.

20.

Intraperitoneal immunotherapy: historical perspectives and modern therapy.

Morano WF, Aggarwal A, Love P, Richard SD, Esquivel J, Bowne WB.

Cancer Gene Ther. 2016 Nov;23(11):373-381. doi: 10.1038/cgt.2016.49. Epub 2016 Nov 11. Review.

PMID:
27834358
21.

Benefit of Radiotherapy in Extraskeletal Myxoid Chondrosarcoma: A Propensity Score Weighted Population-based Analysis of the SEER Database.

Kemmerer EJ, Gleeson E, Poli J, Ownbey RT, Brady LW, Bowne WB.

Am J Clin Oncol. 2018 Jul;41(7):674-680. doi: 10.1097/COC.0000000000000341.

PMID:
27819877
22.

WHipple-ABACUS, a simple, validated risk score for 30-day mortality after pancreaticoduodenectomy developed using the ACS-NSQIP database.

Gleeson EM, Shaikh MF, Shewokis PA, Clarke JR, Meyers WC, Pitt HA, Bowne WB.

Surgery. 2016 Nov;160(5):1279-1287. doi: 10.1016/j.surg.2016.06.040. Epub 2016 Aug 17.

PMID:
27544541
23.

Toward the molecular dissection of peritoneal pseudomyxoma.

Pietrantonio F, Perrone F, Mennitto A, Gleeson EM, Milione M, Tamborini E, Busico A, Settanni G, Berenato R, Caporale M, Morano F, Bossi I, Pellegrinelli A, Di Bartolomeo M, de Braud F, Baratti D, Bowne WB, Kusamura S, Deraco M.

Ann Oncol. 2016 Nov;27(11):2097-2103. Epub 2016 Aug 8.

PMID:
27502722
24.

Disease Biomarkers in Gastrointestinal Malignancies.

Moaven O, Raziee H, Bowne W, Abbaszadegan MR, Fuchs BC.

Dis Markers. 2016;2016:4714910. doi: 10.1155/2016/4714910. Epub 2016 Jul 3. No abstract available.

25.

Hyaluronidase Embedded in Nanocarrier PEG Shell for Enhanced Tumor Penetration and Highly Efficient Antitumor Efficacy.

Zhou H, Fan Z, Deng J, Lemons PK, Arhontoulis DC, Bowne WB, Cheng H.

Nano Lett. 2016 May 11;16(5):3268-77. doi: 10.1021/acs.nanolett.6b00820. Epub 2016 Apr 8.

PMID:
27057591
26.

Ex vivo Efficacy of Anti-Cancer Drug PNC-27 in the Treatment of Patient-Derived Epithelial Ovarian Cancer.

Sarafraz-Yazdi E, Gorelick C, Wagreich AR, Salame G, Angert M, Gartman CH, Gupta V, Bowne WB, Lee YC, Abulafia O, Pincus MR, Michl J.

Ann Clin Lab Sci. 2015 Fall;45(6):650-8.

PMID:
26663795
27.

Palliative Surgery for Advanced Cancer: Identifying Evidence-Based Criteria for Patient Selection: Case Report and Review of Literature.

Foster D, Shaikh MF, Gleeson E, Babcock BD, Ringold D, Bowne WB.

J Palliat Med. 2016 Jan;19(1):22-9. doi: 10.1089/jpm.2015.0146. Epub 2015 Nov 13. Review.

PMID:
26565437
28.

Pancreatic mucinous cystic neoplasm in a transgender patient.

Foster D, Shaikh MF, Gleeson E, Babcock BD, Lin J, Ownbey RT, Hysell ME, Ringold D, Bowne WB.

World J Surg Oncol. 2015 Jun 24;13:205. doi: 10.1186/s12957-015-0620-8.

29.

The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM-2 in the plasma membrane of these cells.

Davitt K, Babcock BD, Fenelus M, Poon CK, Sarkar A, Trivigno V, Zolkind PA, Matthew SM, Grin'kina N, Orynbayeva Z, Shaikh MF, Adler V, Michl J, Sarafraz-Yazdi E, Pincus MR, Bowne WB.

Ann Clin Lab Sci. 2014 Summer;44(3):241-8.

PMID:
25117093
30.

Retroperitoneal Castleman's disease: advocating a multidisciplinary approach for a rare clinical entity.

Williams AD, Sanchez A, Hou JS, Rubin RR, Hysell ME, Babcock BD, Shaikh MF, Weingarten MS, Bowne WB.

World J Surg Oncol. 2014 Feb 4;12:30. doi: 10.1186/1477-7819-12-30.

31.

Anti-cancer peptides from ras-p21 and p53 proteins.

Pincus MR, Fenelus M, Sarafraz-Yazdi E, Adler V, Bowne W, Michl J.

Curr Pharm Des. 2011;17(25):2677-98. Review.

PMID:
21728981
32.

The anti-cancer peptide, PNC-27, induces tumor cell lysis as the intact peptide.

Sookraj KA, Bowne WB, Adler V, Sarafraz-Yazdi E, Michl J, Pincus MR.

Cancer Chemother Pharmacol. 2010 Jul;66(2):325-31. doi: 10.1007/s00280-009-1166-7. Epub 2010 Feb 25.

PMID:
20182728
33.

Anticancer peptide PNC-27 adopts an HDM-2-binding conformation and kills cancer cells by binding to HDM-2 in their membranes.

Sarafraz-Yazdi E, Bowne WB, Adler V, Sookraj KA, Wu V, Shteyler V, Patel H, Oxbury W, Brandt-Rauf P, Zenilman ME, Michl J, Pincus MR.

Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):1918-23. doi: 10.1073/pnas.0909364107. Epub 2010 Jan 11.

34.

Perforated appendicitis presenting as a thigh abscess.

Sookraj KA, Bowne WB, Ghosh BC.

J Am Coll Surg. 2009 Jun;208(6):1142. doi: 10.1016/j.jamcollsurg.2008.10.027. Epub 2008 Nov 20. No abstract available.

PMID:
19476904
35.

The penetratin sequence in the anticancer PNC-28 peptide causes tumor cell necrosis rather than apoptosis of human pancreatic cancer cells.

Bowne WB, Sookraj KA, Vishnevetsky M, Adler V, Sarafraz-Yazdi E, Lou S, Koenke J, Shteyler V, Ikram K, Harding M, Bluth MH, Ng M, Brandt-Rauf PW, Hannan R, Bradu S, Zenilman ME, Michl J, Pincus MR.

Ann Surg Oncol. 2008 Dec;15(12):3588-600. doi: 10.1245/s10434-008-0147-0. Epub 2008 Oct 18.

PMID:
18931881
36.

Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells.

Fu SL, Pierre J, Smith-Norowitz TA, Hagler M, Bowne W, Pincus MR, Mueller CM, Zenilman ME, Bluth MH.

Clin Exp Immunol. 2008 Sep;153(3):401-9. doi: 10.1111/j.1365-2249.2008.03726.x.

37.

The role of the assistant in laparoscopic surgery: important considerations for the apprentice-in-training.

Chiu A, Bowne WB, Sookraj KA, Zenilman ME, Fingerhut A, Ferzli GS.

Surg Innov. 2008 Sep;15(3):229-36. doi: 10.1177/1553350608323061.

PMID:
18757384
38.

Sophorolipids and their derivatives are lethal against human pancreatic cancer cells.

Fu SL, Wallner SR, Bowne WB, Hagler MD, Zenilman ME, Gross R, Bluth MH.

J Surg Res. 2008 Jul;148(1):77-82. doi: 10.1016/j.jss.2008.03.005. Epub 2008 Apr 11.

PMID:
18570934
39.

Site-specific phosphorylation of raf in cells containing oncogenic ras-p21 is likely mediated by jun-N-terminal kinase.

Adler V, Bowne W, Michl J, Sookraj KA, Ikram K, Pestka S, Izotova L, Zenilman M, Friedman FK, Qu Y, Pincus MR.

Ann Clin Lab Sci. 2008 Winter;38(1):47-56.

PMID:
18316782
40.

Two peptides derived from ras-p21 induce either phenotypic reversion or tumor cell necrosis of ras-transformed human cancer cells.

Adler V, Bowne W, Kamran I, Michl J, Friedman FK, Chin E, Zenilman M, Pincus MR.

Cancer Chemother Pharmacol. 2008 Aug;62(3):491-8. Epub 2007 Dec 8.

PMID:
18066549
41.

Castleman's disease in the head of the pancreas: report of a rare clinical entity and current perspective on diagnosis, treatment, and outcome.

Wang H, Wieczorek RL, Zenilman ME, Desoto-Lapaix F, Ghosh BC, Bowne WB.

World J Surg Oncol. 2007 Nov 20;5:133. Review.

42.

Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.

Bowne WB, Michl J, Bluth MH, Zenilman ME, Pincus MR.

Cancer Ther. 2007;5B:331-344.

43.

Invasive amebiasis and ameboma formation presenting as a rectal mass: An uncommon case of malignant masquerade at a western medical center.

Hardin RE, Ferzli GS, Zenilman ME, Gadangi PK, Bowne WB.

World J Gastroenterol. 2007 Nov 14;13(42):5659-61.

44.

Medial-to-lateral laparoscopic colon resection: a view beyond the learning curve.

Kim J, Edwards E, Bowne W, Castro A, Moon V, Gadangi P, Ferzli G.

Surg Endosc. 2007 Sep;21(9):1503-7. Epub 2007 Jul 20.

PMID:
17641928
45.

The dual-specificity kinases, TOPK and DYRK1A, are critical for oocyte maturation induced by wild-type--but not by oncogenic--ras-p21 protein.

Qu Y, Adler V, Izotova L, Pestka S, Bowne W, Michl J, Boutjdir M, Friedman FK, Pincus MR.

Front Biosci. 2007 Sep 1;12:5089-97.

PMID:
17569632
46.

Surgical management of melanoma of the gallbladder: a report of 13 cases and review of the literature.

Katz SC, Bowne WB, Wolchok JD, Busam KJ, Jaques DP, Coit DG.

Am J Surg. 2007 Apr;193(4):493-7. Review.

PMID:
17368297
47.

The role of endoscopic extraperitoneal herniorrhaphy: where do we stand in 2005?

Bowne WB, Morgenthal CB, Castro AE, Shah P, Ferzli GS.

Surg Endosc. 2007 May;21(5):707-12. Epub 2007 Feb 6. Review.

PMID:
17279303
48.

Laparoscopic gastric bypass is superior to adjustable gastric band in super morbidly obese patients: A prospective, comparative analysis.

Bowne WB, Julliard K, Castro AE, Shah P, Morgenthal CB, Ferzli GS.

Arch Surg. 2006 Jul;141(7):683-9.

PMID:
16847241
49.

Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma.

Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, Fong Y, DeMatteo RP, D'Angelica M, Koea J, Blumgart LH.

Ann Surg. 2005 May;241(5):703-12; discussion 712-4.

50.

Merkel cell carcinoma: prognosis and treatment of patients from a single institution.

Allen PJ, Bowne WB, Jaques DP, Brennan MF, Busam K, Coit DG.

J Clin Oncol. 2005 Apr 1;23(10):2300-9.

PMID:
15800320

Supplemental Content

Support Center